Levetiracetam
- Product NDC
- 60432-831
- 11-digit product format
- 604320831
- Labeler code
- 60432
- Product ID
- 60432-831_19af8ef3-5c6c-4c80-8338-fd54e2fcb51b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levetiracetam
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Morton Grove Pharmaceuticals, Inc.
- Application
- ANDA090028
- Marketing category
- ANDA
- Marketing start
- 2010-03-18
- Marketing end
- 0000-00-00
- Substance
- LEVETIRACETAM
- Active strength
- 100 mg/mL
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 60432-831-16 | Levetiracetam | 473 mL in 1 BOTTLE, PLASTIC | SOLUTION | 473 | | 14 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| Levetiracetam | ACTIVE INGREDIENT | 44YRR34555 | LEVETIRACETAM SOLUTION [MORTON GROVE PHARMACEUTICALS, INC.] | 7 | |
| Levetiracetam | ACTIVE MOIETY | 44YRR34555 | LEVETIRACETAM SOLUTION [MORTON GROVE PHARMACEUTICALS, INC.] | 7 | |
| ACESULFAME POTASSIUM | INACTIVE INGREDIENT | 23OV73Q5G9 | LEVETIRACETAM SOLUTION [MORTON GROVE PHARMACEUTICALS, INC.] | 7 | |
| AMMONIUM GLYCYRRHIZATE | INACTIVE INGREDIENT | 3VRD35U26C | LEVETIRACETAM SOLUTION [MORTON GROVE PHARMACEUTICALS, INC.] | 7 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | LEVETIRACETAM SOLUTION [MORTON GROVE PHARMACEUTICALS, INC.] | 7 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | LEVETIRACETAM SOLUTION [MORTON GROVE PHARMACEUTICALS, INC.] | 7 | |
| MALTITOL | INACTIVE INGREDIENT | D65DG142WK | LEVETIRACETAM SOLUTION [MORTON GROVE PHARMACEUTICALS, INC.] | 7 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | LEVETIRACETAM SOLUTION [MORTON GROVE PHARMACEUTICALS, INC.] | 7 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | LEVETIRACETAM SOLUTION [MORTON GROVE PHARMACEUTICALS, INC.] | 7 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | LEVETIRACETAM SOLUTION [MORTON GROVE PHARMACEUTICALS, INC.] | 7 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | LEVETIRACETAM SOLUTION [MORTON GROVE PHARMACEUTICALS, INC.] | 7 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 60432-831 | LEVETIRACETAM SOLUTION [MORTON GROVE PHARMACEUTICALS, INC.] | 14 | Legacy NDC, 1 package rows | 20201224_3edcaae5-81bb-4a18-8bfd-834835187b13.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60432-831-16 | 60432083116 | 473 mL in 1 BOTTLE, PLASTIC (60432-831-16) | 473 ml | 2010-03-18 | 0000-00-00 | No | No | Current |